Patents by Inventor Kei TAKEDOMI

Kei TAKEDOMI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230086093
    Abstract: The present invention provides a mutant RSV F protein having a mutation, wherein the mutation is a substitution of a leucine corresponding to a leucine at position 141 of an amino acid sequence of SEQ ID NO: 1 or a leucine corresponding to a leucine at position 142 with a cysteine, and a substitution of a leucine corresponding to a leucine at position 373 with a cysteine, and a disulfide bond is formed between the cysteines. Further provided is a mutant RSV F protein having a mutation, wherein the mutation is a substitution of a glutamic acid corresponding to a glutamic acid at position 60 of the amino acid sequence of SEQ ID NO: 1 with a non-acidic amino acid.
    Type: Application
    Filed: December 23, 2020
    Publication date: March 23, 2023
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Tomoharu HOGIRI, Hiroyuki KISHIDA, Kei TAKEDOMI, Davide BRANDUARDI, Eliud OLOO, Eric FEYFANT, Osamu ICHIHARA